NSB
Click for more information
2.17% 4.5¢ neuroscientific biopharmaceuticals ltd

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4

  1. KingHoves
    125 Posts.
    lightbulb Created with Sketch. 228
    clock Created with Sketch.
    27/02/22
    18:47
    Post #: 59855091
    Valid concern! From the Ann: Investor Webinar Presentation on the 17/11/21 they stated:

    https://hotcopper.com.au/data/attachments/4123/4123531-2379a155bdcaaa028926a976e722bdb5.jpg

    Mind you this includes both the FIH trial for Alzheimer's and the FIP trial for Glaucoma. It would be very disappointing should a CR be required before either of these outcomes. $3m spend in the last quarter on pre-clinical activities seems high, lets hope some of this is upfront expenditure for the trials


    NSB Price at posting: 28.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
4.5¢ 		Change
-0.001(2.17%) 		Mkt cap ! $6.507M
Open High Low Value Volume
4.6¢ 4.6¢ 4.5¢ $31.09K 689.1K

Buyers (Bids)

No. Vol. Price($)
1 401 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 83911 3
View Market Depth
Last trade - 14.21pm 23/08/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.